A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective StudySara Gagno, Giuseppe Toffoli, Mario D’Andrea et al.|Clinical Breast Cancer|2018Cited by 10
The Enriched Sequencing Method for Detection of K-Ras Mutations Enhances the Identification of Primary Resistant Colorectal Cancers to PanitumumabLuciano Stumbo, Antonio Marchetti, Salvatore Tumolo et al.|Annals of Oncology|2013Cited by 0